Lipovisc (Carbomer)

Lipovisc, a carbomer‑based ophthalmic viscosity agent, is employed to improve ocular surface retention in various eye‑care applications.

• Dry eye syndrome: prolongs residence time of lubricating drops, enhancing ocular surface hydration.
• Post‑operative eye care: maintains therapeutic eye drop contact after surgery, supporting healing.
• Ocular surface disease: increases viscosity of medicated solutions to improve drug delivery to the cornea and conjunctiva.
• Contact lens discomfort: provides a thicker formulation that reduces irritation.

• Carbomer is a high‑molecular‑weight polymer that forms a cross‑linked gel when neutralized. In ophthalmic solutions it binds water, creating a viscoelastic matrix that increases the formulation’s viscosity. The heightened viscosity slows tear‑film turnover, allowing the active agents in the eye drop to remain on the ocular surface for a longer period, thereby enhancing drug absorption and therapeutic effect.

Carbomer may cause local ocular reactions, most of which are mild and transient.

Common Side Effects

• Eye irritation: mild burning or stinging upon instillation.
• Redness: temporary conjunctival hyperemia.
• Blurred vision: short‑term visual disturbance that resolves quickly.
• Tearing: increased lacrimation after application.
• Foreign body sensation: feeling of grit in the eye.

Serious or Rare Side Effects

• Allergic reaction: swelling, itching, or rash requiring medical attention.
• Corneal ulceration: persistent ulcer formation needing urgent care.
• Severe inflammation: marked uveitis or keratitis.
• Vision loss: sudden decrease in visual acuity.
• Anaphylaxis: systemic hypersensitivity reaction (extremely rare).

When using Lipovisc, consider the following precautions to ensure safety and efficacy.

• Patient history: assess for known hypersensitivity to carbomer or similar polymers.
• Concomitant eye drops: avoid mixing with other ophthalmic solutions unless compatibility is confirmed.
• Contact lens wear: remove lenses before instillation and wait before reinserting.
• Ocular infection: defer use if active infection is present until treated.
• Pregnancy and lactation: safety not established; use only if benefit outweighs risk.
• Store at ambient temperature: keep below 25 °C, protect from moisture and direct sunlight.

Carbomer can interact physically or chemically with certain ophthalmic products, which may affect formulation stability or ocular tolerance.

Major Interactions (Avoid)

• Preservative incompatibility: carbomer may precipitate with high concentrations of benzalkonium chloride.
• Acidic eye drops: low pH formulations can cause gel destabilization.
• Anticholinergic eye drops: may reduce carbomer’s viscosity‑enhancing effect.

Moderate Interactions (Monitor Closely)

• Other polymers: co‑administration with hyaluronic acid may alter viscosity profile.
• Topical antibiotics: monitor for increased irritation.
• Anti‑inflammatory drops: assess for any change in drug absorption.